SciTech Development secures second FDA clearance for ST-001 in early-stage cancer trials

Avidity Biosciences receives Orphan Drug designation in Japan for del-desiran in treatment of myotonic dystrophy type 1

Gift of Life Biologics and Cellex Cell Professionals advance cell and gene therapy manufacturing through strategic partnership

ProRx Pharma expands wellness portfolio with launch of four preventative injectables

Xeltis advances toward EUR10m European Innovation Council investment to support commercialisation of vascular implant

European Commission approves subcutaneous RYBREVANT with ENHANZE for advanced EGFR-mutated lung cancer

ResVita Bio's RVB-003 receives US FDA Orphan Drug Designation

Tasman Therapeutics to raise USD175m in Series A funding

Variant's VAR002 receives positive European regulatory feedback

Amgen's UPLIZNA receives US FDA approval for IgG4-RD

Sanofi's rilzabrutinib receives US orphan drug designation for two rare diseases

Hoth Therapeutics partners with Washington University to advance Alzheimer's disease research

Mabwell's B7-H3-targeting ADC clinical trial application receives Chinese regulatory approval

Amygdala Neurosciences selects ANS-858 as lead clinical candidate for substance use disorder

Quest Diagnostics expands HPV self-collection screening option